SG healthcare analytics startup gets $45m injection
Holmusk is a data analytics company aiming to solve complex problems in behavioral health. The company is headquartered in Singapore and New York.
Funding details
- Funding amount: US$45 million
- Lead investor: Veradigm
- Other investors: Heritas Capital, Health Catalyst Capital, Novartis (dRx Capital), Northwell Holdings
- Stage: Series B
- Source
More details
Holmusk→
|
||
| Stage | Amount (US$) | Investors |
| Pre-series A | 9.8 million | Heritas Capital |
| Series A | 21.5 million | Heritas Capital, Optum Ventures, Health Catalyst Capital |
| Series B | 45 million | Veradigm, Heritas Capital, Northwell Holdings, Novartis (dRx Capital), Health Catalyst Capital |
| Total | 76.3 million | |
See also: Temasek-backed Halodoc enabled sale of restricted drugs
Editing by Dhania Putri Sarahtika
(And yes, we’re serious about ethics and transparency. More information here.)




